Completed NA INTERVENTIONAL 2-arm NCT00633971

Treatment Trial for Post-Thrombotic Syndrome

A Randomized Trial to Determine the Impact of Lymphedema Therapy on Quality of Life and Disease Severity in Patients With Post-Thrombotic Syndrome

Sponsor: University of Vermont

Conditions Post Thrombotic Syndrome

Interventions complex lymphedema therapy

Updated 6 times since 2017 Last updated: Sep 15, 2020 Started: Mar 31, 2008 Primary completion: Jun 30, 2010 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00633971, this NA trial focuses on Post Thrombotic Syndrome and remains completed. Sponsored by University of Vermont, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2020 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE3 → NA
Jun 2018 — Oct 2020 [monthly]

Unknown Status PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Vermont

Data source: University of Vermont

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Burlington, United States